Muscle damage. Disorders of muscle in diseases classified elsewhere
Conditions
Interventions
Intervention 1: 0.1 grams of glutamine per kg of body weight (Karen pharmaceutical company) was combined with 300 ml of water. Intervention 2: Maltodextrin Placebo group of 0.1 grams per kilogram of b
Prevention
Placebo
0.1 grams of glutamine per kg of body weight (Karen pharmaceutical company) was combined with 300 ml of water
Maltodextrin Placebo group of 0.1 grams per kilogram of body weight, which is combined with 300 ml of water.
Sponsors
National Olympic Academy
Eligibility
Sex/Gender
Male
Age
20 Years to 30 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: men; non athletes; non-smokers with normal BMI and age between 20 to 30 years old. Exclusion criteria: being athlete; smoking; an abnormal BMI (under weight - overweight and obesity) and non-compliance with conditions such as changes in diet during the study; taking drug or certain supplements and age less than 20 years over 30 years old.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum creatine kinase enzyme. Timepoint: Zero, 24 and 48 hours after intervention. Method of measurement: Level of enzyme activity by photometric method.;Muscle pain perception. Timepoint: Zero, 24 and 48 hours after intervention. Method of measurement: Pain is measured using a scale numbered graphics PAS.;Range of motion. Timepoint: Zero, 24 and 48 hours after intervention. Method of measurement: Goniometer Lafayette. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHadi Atarod
Shahid Sadooghi University of Medical Sciences
Outcome results
None listed